Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124253782 | 12425378 | 2 | F | 20160516 | 20160601 | 20160831 | PER | US-MYLANLABS-2016M1016651 | MYLAN | 0.00 | F | Y | 49.89000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124253782 | 12425378 | 1 | PS | LIDOCAINE. | LIDOCAINE | 1 | Cutaneous | 1 DF, QD ON 12 HOURS | U | U | 202346 | 1 | DF | CUTANEOUS PATCH | QD | ||||
| 124253782 | 12425378 | 2 | SS | LIDOCAINE. | LIDOCAINE | 1 | U | U | 202346 | CUTANEOUS PATCH | |||||||||
| 124253782 | 12425378 | 3 | SS | LIDOCAINE. | LIDOCAINE | 1 | U | U | 202346 | CUTANEOUS PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124253782 | 12425378 | 1 | Pain |
| 124253782 | 12425378 | 2 | Arthralgia |
| 124253782 | 12425378 | 3 | Off label use |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124253782 | 12425378 | Drug ineffective for unapproved indication | |
| 124253782 | 12425378 | Product adhesion issue | |
| 124253782 | 12425378 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124253782 | 12425378 | 1 | 201012 | 0 |